www.fdanews.com/articles/149541-threshold-pharma-cancer-trial-result-spooks-investors
Threshold Pharma Cancer Trial Result Spooks Investors
September 18, 2012
An experimental pancreatic cancer treatment from Threshold Pharmaceuticals failed to show statistically significant improvement in overall survival, spooking investors and sending its shares down as much as a third.
Reuters
Reuters